1. Home
  2. KROS vs CCRN Comparison

KROS vs CCRN Comparison

Compare KROS & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • CCRN
  • Stock Information
  • Founded
  • KROS 2015
  • CCRN 1986
  • Country
  • KROS United States
  • CCRN United States
  • Employees
  • KROS N/A
  • CCRN N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • CCRN Professional Services
  • Sector
  • KROS Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • KROS Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • KROS 589.8M
  • CCRN 588.1M
  • IPO Year
  • KROS 2020
  • CCRN N/A
  • Fundamental
  • Price
  • KROS $10.86
  • CCRN $18.18
  • Analyst Decision
  • KROS Buy
  • CCRN Buy
  • Analyst Count
  • KROS 11
  • CCRN 3
  • Target Price
  • KROS $45.33
  • CCRN $18.31
  • AVG Volume (30 Days)
  • KROS 2.0M
  • CCRN 537.9K
  • Earning Date
  • KROS 02-26-2025
  • CCRN 02-19-2025
  • Dividend Yield
  • KROS N/A
  • CCRN N/A
  • EPS Growth
  • KROS N/A
  • CCRN N/A
  • EPS
  • KROS N/A
  • CCRN N/A
  • Revenue
  • KROS $651,000.00
  • CCRN $1,448,099,000.00
  • Revenue This Year
  • KROS $303.39
  • CCRN N/A
  • Revenue Next Year
  • KROS N/A
  • CCRN N/A
  • P/E Ratio
  • KROS N/A
  • CCRN N/A
  • Revenue Growth
  • KROS 8037.50
  • CCRN N/A
  • 52 Week Low
  • KROS $9.78
  • CCRN $9.58
  • 52 Week High
  • KROS $73.00
  • CCRN $23.15
  • Technical
  • Relative Strength Index (RSI)
  • KROS 20.25
  • CCRN 76.23
  • Support Level
  • KROS $9.78
  • CCRN $18.10
  • Resistance Level
  • KROS $16.49
  • CCRN $18.30
  • Average True Range (ATR)
  • KROS 0.92
  • CCRN 0.10
  • MACD
  • KROS 0.97
  • CCRN -0.22
  • Stochastic Oscillator
  • KROS 14.52
  • CCRN 66.67

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: